First 25 Flashcards
acetaminophen and codeine (combination)
MOA: Inhibit the synthesis of prostaglandins in the central nervous system and peripherally block pain impulse generation; produces antipyresis from inhibition of hypothalamic heat-regulating center. Binds to opiate receptors in the CNS, causing inhibition of ascending pain pathways, altering the perception of and response to pain; causes cough suppression by direct central action in the medulla; produces generalized CNS depression Schedule: III Dosing: 300mg/30mg q 4 hours PRN Max 4000mg/360mg per 24 hours Contraindication(s): Significant respiratory depression postoperative pain management in children who have undergone tonsillectomy and/or adenoidectomy GI obstruction, including paralytic ileus (known or suspected) concurrent use with monoamine oxidase inhibitors (MAOIs) or use of MAOIs within the last 14 days. BBW: • Risk of medication errors • Addiction, abuse, and misuse • Life-threatening respiratory depression • Accidental ingestion • Neonatal opioid withdrawal syndrome • Death related to ultra-rapid metabolism of codeine to morphine • Hepatoxicity • Interactions with drugs affecting cytochrome P450 • Risks from concomitant use with benzodiazepines or other CNS depressants Key Points: Drowsiness and sedation Constipation PruritisAvoid alcohol or other sedating agents and other APAP products
adalimumab
MOA: Binds to human tumor necrosis factor alpha (TNF-alpha), thereby interfering with binding to TNFα receptor sites and subsequent cytokine-driven inflammatory processes Schedule: legend Dosing: 40mg SQ every other week Contraindication(s): None BBW: • Serious infections • Malignancy Key Points: Do not start or take the next dose if the patient is sick Patient should complete Hepatitis B virus and tuberculosis screening prior to starting the first dose Injection site reaction (burning, itching, pain, rash, and/or redness) are common but usually well-toleratedThe drug takes some time to work (RA); do not stop the drug when patients do not see results immediately
Albuterol
MOA: Relaxes bronchial smooth muscle by action on beta2-receptors Schedule: legend Dosing: 1 to 2 inhalations q 4 to 6 hours PRN Contraindication(s): Severe hypersensitivity to milk proteins BBW: • None Key Points: Upper respiratory tract infections Cough
alendronate
MOA: Inhibits bone resorption via actions on osteoclasts or on osteoclast precursors; decreases the rate of bone resorption, leading to an indirect increase in bone mineral density Schedule: legend Dosing: Prophylaxis (females): 5mg once daily or 35mg once weekly Treatment (females/males): 10mg once daily or 70mg once weekly Contraindication(s): Hypocalcemia Esophageal abnormalities Inablility to sit or stand upright for 30 minutes BBW: • None Key Points: Take on an empty stomach before breakfast with a full glass of water. Do not eat or drink, or take other meds for at least 30 mins post dose. Remain upright for 30 minutes after dose Notify your dentist that you are taking this medicine (due to very rare osteonecrosis of the jaw) Maintain calcium & Vit D supplementation if diet inadequate Bone pain
Allopurinol
MOA: Inhibits xanthine oxidase, the enzyme responsible for the conversion of hypoxanthine to xanthine to uric acid Schedule: legend Dosing: Initiate 100mg once daily and increase every week by 100mg/day until desired uric acid level is achieved Max 800mg/day Contraindication(s): Hypersensitivity BBW: • None Key Points: Diarrhea Skin Rash Keep taking even if you are not experiencing a gout flare
Alprazolam
MOA: Enhances the inhibitory effect of GABA on neuronal excitability results by increased neuronal membrane permeability to chloride ions Schedule: IV Dosing: 0.25mg to 1mg TID Usual range 4mg/day to 6mg/day Contraindication(s): Acute narrow-angle glaucoma Concurrent use with potent CYP 3A4 inhibitors BBW: • Risk from concomitant use with opiods Key Points: Drowsiness and sedation Avoid alcohol or other sedating agents Skin Rash
Amitriptyline
Generic : elavil MOA: Increases the synaptic concentration of serotonin and/or norepinephrine in the central nervous system by inhibition of their reuptake by the presynaptic neuronal membrane pump Schedule: legend Dosing: 25mg to 50mg daily at bedtime or in divided doses and gradually increase to 100mg to 300mg daily Ususal range 100mg to 300mg Contraindication(s): MAOI use within 14 days Acute recovery phase following MI BBW: • Suicidality and antidepressant drugs Key Points: Heart arrythymias Dry mouth, dry eyes, constipation, urinary retention (anticholinergic) TremorSedation; take at bedtime if it causes sleepiness
Aripiprazole
Brand: Abilify MOA: Partial agonist of D2 and 5-HT1A receptors, and an antagonist at the 5-HT2A receptor Schedule: legend Dosing: Deperession adjunct: 2mg to 5mg ocne daily (Max: 15mg/day) Schizophrenia: 10mg to 15mg once daily (Max 30mg/day) Bipolar I: 15mg to 30mg once daily (Max 30mg/day) Contraindication(s): Hypersensitivity BBW: • Increased mortality in elderly patients with dementia-related psychosis • Suicidality and antidepressant drugs Key Points: Headache Increased glucose SedationPotential extrapyramidal reactions
Atomoxetine
Brand: Straterra MOA: Selectively inhibits the reuptake of norepinephrine Schedule: legend Dosing: 40mg to 80mg daily in a single dose or 2 evenly divided doses Max 100mg/day Contraindication(s): MAOI use within 14 days Narrow-angle glaucoma History of pheochromocytoma Cardiac or vascular disorders that will deteriorate and cause increases in blood pressure or pulse BBW: • Suicidal ideation in children and adolescents Key Points: Headache Insomnia Decreased appetiteDry mouth
Baclofen
Brand: Lioresal MOA: Inhibits the transmission of both monosynaptic and polysynaptic reflexes at the spinal cord level, possibly by hyperpolarization of primary afferent fiber terminals Schedule: legend Dosing: 5mg to 20mg TID Max 80mg/day Contraindication(s): Hypersensitivity Intrathecal: IV, IM, SubQ, or epidural administration BBW: • Abrupt withdrawal (injection) Key Points: Hypotonia Drowsiness and confusion Nausea and VomittingHeadache
Benztropine
Brand: Cogentin MOA: Possesses both anticholinergic and antihistaminic effects Schedule: legend Dosing: 1mg to 2mg 2 to 3 times daily Max 6mg/day Contraindication(s): Hypersensitivity Children less than 3 years old BBW: • None Key Points: Tachycardia Dry mouth, dry eyes, constipation, urinary retention (anticholinergic)
Buedesonide
Brand name: Rhinocort, Pulmicort, Uceris, Entocort MOA: Decreases inflammation by suppression of migration of polymorphonuclear leukocytes and reversal of increased capillary permeability Schedule: legend Dosing: Oral: 9mg q AM for 8 weeks Intranasal: 1 to 2 sprays (32mcg to 64mcg) in each nostril once daily Inhaled: 360mcg BID up to 720mcg BID Contraindication(s): Primary treatment of acute asthma episodes Severe hypersensitivity to milk proteins BBW: • None Key Points: Inhaled: Oral thrush; upper respiratory tract infection; cough Topical: Apply thin layer and avoid broken skin and sensiteve areas Oral: Headache; Diarrhea; Respiratory tract infection; Decreased cortisol; Take with food
Buesonide and Formoterol
Brand: Symbicort MOA: Decreases inflammation by suppression of migration of polymorphonuclear leukocytes and reversal of increased capillary permeability Formoterol relaxes bronchial smooth muscle by selective action on beta-2 receptors Schedule: legend Dosing: 2 inhalations BID Titrate dose by choosing higher strength Contraindication(s): Primary treatment of acute asthma or COPD episodes BBW: • Asthma-related death Key Points: Oral thrush Cough Upper respiratory tract infectionHeadache
Buprenorphine
Brand: Buprenx, Butrans MOA: Binds to mu opiate receptors in the CNS; displays partial mu agonist and weak kappa antagonist activity Schedule: III Dosing: Oral SLT: 12mg to 16mg once daily Buccal Film: 150mcg q 12 hours Contraindication(s): Significant respiratory depression Acute or severe asthma GI obstruction, including paralytic ileus (known or suspected) BBW: • Addiction, abuse, and misuse (buccal film, injection, transdermal patch) • Life-threatening respiratory depression (buccal film, injection, transdermal patch) • Accidental exposure (buccal film, transdermal patch) • Neonatal opioid withdrawal syndrome (buccal film, injection, transdermal patch) • Risk associated with insertion and removal (Probuphine implant) • Risks from concomitant use with benzodiazepines or other CNS depressants (buccal film, injection, transdermal patch) Key Points: Headache Sedation REMS drug
Buprenorphine and Naloxone
Brand: Suboxone, Zubsolv MOA: Buprenorphine binds to mu opiate receptors in the CNS; displays partial mu agonist and weak kappa antagonist activity Naloxone is a pure opioid antagonist that competes and displaces opioids at opioid receptor sites Schedule: III Dosing: SL: 16mg/4mg once daily Buccal Film: 8.4mg/1.4mg once daily Contraindication(s): Hypersensitivity BBW: • None Key Points: Headache Withdrawal syndrome PainDiaphoresis